These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19549432)

  • 1. Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids.
    Berger WE; Kerwin E; Bernstein DI; Pedinoff A; Bensch G; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):304-14. PubMed ID: 19549432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroids.
    Meltzer EO; Korenblat PE; Weinstein SF; Noonan M; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):293-303. PubMed ID: 19549431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma.
    Pearlman DS; Berger WE; Kerwin E; Laforce C; Kundu S; Banerji D
    J Allergy Clin Immunol; 2005 Dec; 116(6):1206-12. PubMed ID: 16337447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciclesonide improves health-related quality of life in adults and adolescents with mild-to-moderate persistent asthma.
    Nathan RA; Kanter L; Ostrom NK
    Allergy Asthma Proc; 2008; 29(5):521-7. PubMed ID: 18684342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily ciclesonide in children: efficacy and safety in asthma.
    Gelfand EW; Georgitis JW; Noonan M; Ruff ME
    J Pediatr; 2006 Mar; 148(3):377-83. PubMed ID: 16615971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.
    Bateman ED; Cheung D; Lapa e Silva J; Göhring UM; Schäfer M; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(3):489-98. PubMed ID: 18178494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
    Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A
    Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
    Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
    Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma.
    von Berg A; Engelstätter R; Minic P; Sréckovic M; Garcia Garcia ML; Latoś T; Vermeulen JH; Leichtl S; Hellbardt S; Bethke TD
    Pediatr Allergy Immunol; 2007 Aug; 18(5):391-400. PubMed ID: 17617808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: a double-blind, placebo-controlled study.
    Adachi M; Ishihara K; Inoue H; Kudo K; Takahashi K; Morita Y; Masuda K; Takada Y; Kato R; Miyamoto T
    Respirology; 2007 Jul; 12(4):566-72. PubMed ID: 17587424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily ciclesonide via metered-dose inhaler: Similar efficacy and safety with or without a spacer.
    Engelstätter R; Szlávik M; Gerber C; Beck E
    Respir Med; 2009 Nov; 103(11):1643-50. PubMed ID: 19596188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma.
    Knox A; Langan J; Martinot JB; Gruss C; Häfner D
    Curr Med Res Opin; 2007 Oct; 23(10):2387-94. PubMed ID: 17714607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma.
    Langdon CG; Adler M; Mehra S; Alexander M; Drollmann A
    Respir Med; 2005 Oct; 99(10):1275-85. PubMed ID: 16024244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
    Magnussen H; Hofman J; Staneta P; Lawo JP; Hellwig M; Engelstätter R
    J Asthma; 2007 Sep; 44(7):555-63. PubMed ID: 17885859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.